MDBH Form 4/A: Director awarded RSUs and stock options with $20 performance hurdle
Rhea-AI Filing Summary
Anthony DiGiandomenico, a director and 10% owner of MDB Capital Holdings, LLC (MDBH), reported derivative awards issued on 04/28/2025. The filing shows 900,000 restricted stock units (RSUs) and an award of 900,000 employee stock options tied to Class A shares.
Of the RSUs, 400,000 vest on a time schedule (200,000 immediately, then 22 monthly installments of 8,333 and a final 8,341 on March 15, 2027). The remaining 500,000 are performance-based, vesting if Class A shares trade at an average of $20.00 for 30 trading days or upon distributions valued at $20.00 per share. The options carry an exercise price of $4.25 and expire on 04/28/2035.
Positive
- 500,000 performance-based RSUs tie a material portion of awards to a clear $20.00 per-share performance threshold or equivalent distributions.
- 400,000 time-based RSUs include immediate vesting of 200,000 and structured monthly vesting, aligning retention incentives.
- Options have a long term with expiration on 04/28/2035, giving a multiyear window for value realization.
Negative
- The combined awards total 900,000 RSUs and 900,000 options, which could result in meaningful share dilution if fully issued and exercised.
- Options carry an exercise price of $4.25; exercise would increase shares outstanding and affect ownership percentages.
- Performance vesting requires a $20.00 trigger or equivalent distributions, which may delay shareholder-aligned outcomes until significant stock performance or distributions occur.
Insights
TL;DR: Insider awards total significant equity exposure: 900k RSUs and 900k options; time and performance vesting could affect dilution and alignment.
The filing documents issuance of 900,000 RSUs and 900,000 employee stock options. Time-based RSUs include immediate vesting of 200,000 shares and scheduled monthly vesting ending with a tranche on 03/15/2027. Performance RSUs require a $20.00 average trading threshold or equivalent distributions to vest. Options are exercisable from 04/28/2025 and expire 04/28/2035 with an exercise price of $4.25. For investors, key facts are the size of awards and the mix of time- and performance-based vesting; these determine timing of potential dilution and management incentive alignment.
TL;DR: A director and 10% owner received large, mixed-condition equity grants; governance review should note award size, vesting terms, and performance hurdles.
The reporting person is identified as both a director and a 10% owner. The grants comprise a combination of service-vesting and performance-vesting awards, with explicit performance conditions tied to a $20.00 per-share metric or distributions. The filing references an Exhibit 24 power of attorney. Governance considerations from the facts presented include the awards' scale relative to insider ownership, the duration of option rights through 2035, and the specific vesting mechanics that condition realization of value.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | RSU | 900,000 | $0.00 | -- |
| Grant/Award | Employee Stock Option | 900,000 | $0.00 | -- |
Footnotes (1)
- 400,000 Class A Shares will vest as follows: 200,000 shares vest immediately on grant and the remainder vest in 22 equal monthly installments of 8,333 shares for each complete subsequent month of Continuous Service (as defined in the 2022 Equity Performance Plan) and 8,341 will vest on March 15, 2027. 500,000 Class A Shares are performance-based and vest upon the date on which either of the following occurs during the Exercisability Period (as defined in the Plan and option agreement: (x) a Class A Share has traded in the market on which the Class A Shares are listed for at least thirty (30) trading days at an average price of $20.00 or more, whether consecutive or non-consecutive, or (y) there are distributions of cash, stock or other property by the Company on the Class A Shares, at a value of $20.00 or more in the aggregate per Class A Share.
